Impact of spasticity on quality of life of Lebanese individuals with spinal cord injury: Validity and reliability of the Arabic modified patient-reported impact of spasticity measure

The Journal of Spinal Cord Medicine, 2025 · DOI: 10.1080/10790268.2023.2251207 · Published: September 6, 2023

Spinal Cord Injury Participation Neurology

Simple Explanation

This study translated and adapted a questionnaire (mPRISM) into Arabic to measure the impact of spasticity on the quality of life for Lebanese individuals with spinal cord injury (SCI). The study then checked if the Arabic version of the questionnaire (AR-mPRISM) was a reliable and valid tool. The mPRISM questionnaire was translated to Arabic, and pilot testing of the pre-final version was conducted to assess the relevance and comprehensibility of the translation. The study found that the AR-mPRISM is a valid and reliable tool for assessing the impact of spasticity on the quality of life for Arabic-speaking individuals with SCI.

Study Duration

3 Months

Participants

107 individuals with SCI

Evidence Level

Cross-sectional study

Key Findings

1
The Arabic version of mPRISM (AR-mPRISM) was successfully translated and cross-culturally adapted for Lebanese individuals with SCI.
2
Exploratory factor analysis revealed a 5-domain structure in the AR-mPRISM, explaining 69.631% of the total variance, indicating good construct validity.
3
The study demonstrated convergent validity through significant associations between AR-mPRISM dimensions and sociodemographic and injury-related factors.

Research Summary

This study aimed to translate and validate the modified Patient-Reported Impact of Spasticity Measure (mPRISM) into Arabic (AR-mPRISM) for use with Lebanese individuals with spinal cord injury (SCI). The AR-mPRISM demonstrated good construct and convergent validity, as well as high internal consistency, making it a reliable tool for assessing the impact of spasticity on the quality of life of Arabic-speaking SCI patients. The findings support the use of AR-mPRISM in clinical practice and research to better understand and manage spasticity in Arabic-speaking SCI populations.

Practical Implications

Clinical Assessment

AR-mPRISM can be used by clinicians to assess the impact of spasticity on the QOL of Arabic-speaking SCI patients.

Treatment Planning

The AR-mPRISM results can inform the development of targeted interventions to address the specific needs of individuals with SCI and spasticity.

Research Tool

AR-mPRISM can be used in research studies to evaluate the effectiveness of different treatments for spasticity in Arabic-speaking populations.

Study Limitations

1
Data was gathered through a self-reported online survey without any clinical data, so the responses can be affected by personal/social factors.
2
Test-retest reliability wasn’t evaluated since data collection was anonymous through the online survey.
3
Convergent validity was not performed by correlating the scale with the gold standard measure since there are no validated Arabic spasticity measures.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury